FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely to the field of oncology, and is intended for the prevention and treatment of lung cancer. A combination of therapeutically effective amounts of (S)-N-(4-(3-(1H-1,2,4-triazole-1-yl)-4-(3,4,5-trimethoxybenzoyl) phenyl) thiazole-2-yl)-2-amino-3-methylbutanamide for the prevention or treatment of lung cancer is presented, represented by the following formula 2, or its pharmacologically acceptable salt and the therapeutically effective amount of docetaxel or its pharmacologically acceptable salt. A method for the treatment of lung cancer is also presented, including the introduction of the above combination and the use of a combination to obtain a drug for the treatment of lung cancer.
EFFECT: presented group of inventions provides an effective method for the treatment of lung cancer.
formula 2
9 cl, 6 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR PREVENTING OR TREATING MALIGNANT TUMOUR, COMPRISING AGENT DESTROYING VESSELS, AND IMMUNE CONTROL POINT INHIBITOR | 2018 |
|
RU2738369C1 |
| COMBINED COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING BENZOPHENONE-THIAZOLE DERIVATIVES AS VDA AND TOPOISOMERASE INHIBITOR | 2017 |
|
RU2724341C1 |
| COMPOUNDS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER AND OVARIAN CANCER | 2019 |
|
RU2776897C2 |
| COMBINATION OF MCL-1 INHIBITOR AND TAXANE COMPOUND, THEIR APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2763544C2 |
| COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
| COMPOUND FOR TREATING CANCER | 2014 |
|
RU2708247C2 |
| COMPOUNDS FOR CANCER TREATMENT | 2011 |
|
RU2762111C1 |
| THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS THEREOF WITH ANTICANCER AGENTS | 2019 |
|
RU2824502C2 |
| COMBINATION CONTAINING IRON COMPLEX AND ANTINEOPLASTIC AGENT, AND USE THEREOF | 2007 |
|
RU2469721C2 |
| COMPOUNDS FOR CANCER TREATMENT | 2009 |
|
RU2514427C2 |
